What is the recommended tapering schedule for Celexa (citalopram) 20mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Celexa (Citalopram) 20mg

For citalopram 20mg, reduce the dose by 10% of the original dose (2mg) every 2-4 weeks, which means stepping down to 18mg, then 16mg, then 14mg, and so on, with slower monthly reductions for patients on long-term therapy. 1

Specific Tapering Schedule

Standard Taper Protocol

  • Reduce by 2mg (10% of 20mg) every 2-4 weeks until reaching very low doses 1
  • For patients on citalopram for years, slow to 10% reductions per month or less 1
  • Monitor for withdrawal symptoms after each dose reduction before proceeding to the next step 1

Why Hyperbolic (Proportional) Tapering Matters

  • Do NOT use alternate-day dosing (e.g., 20mg every other day) as this causes severe receptor occupancy fluctuations and withdrawal symptoms 2
  • SSRIs like citalopram have a hyperbolic relationship between dose and serotonin transporter occupancy, meaning equal dose reductions at lower doses cause disproportionately larger biological effects 3
  • Taper to doses much lower than minimum therapeutic doses (well below 10mg) before complete cessation to minimize withdrawal 3

Practical Dosing Steps from 20mg

  1. 20mg → 18mg (hold 2-4 weeks)
  2. 18mg → 16mg (hold 2-4 weeks)
  3. 16mg → 14mg (hold 2-4 weeks)
  4. 14mg → 12mg (hold 2-4 weeks)
  5. 12mg → 10mg (hold 2-4 weeks)
  6. Continue reducing by 10% of the previous dose (not original): 10mg → 9mg → 8mg → 7mg → 6mg → 5mg → 4.5mg → 4mg → 3.5mg → 3mg, etc. 3
  7. Final doses may need to be as low as 0.5mg before complete cessation 3, 4

Managing Withdrawal Symptoms

Common Withdrawal Symptoms to Monitor

  • Dizziness, nausea, headache, paresthesia (tingling/electric shock sensations) 1
  • Irritability, anxiety, insomnia 1
  • These symptoms typically emerge within days of dose reduction 3

Management Strategy

  • If severe withdrawal occurs, return to the previous well-tolerated dose and slow the taper further 1
  • For insomnia specifically, consider short-term non-benzodiazepine sleep aids 1
  • Do not push forward if symptoms are severe—pause the taper and stabilize 1

Duration Expectations

  • Minimum tapering duration: 2-3 months for short-term users 1
  • Extended tapering: 6-12 months or longer for patients on long-term therapy 1
  • Research shows slower tapers over months are associated with lower relapse rates compared to rapid tapers over weeks 3, 5

Critical Pitfalls to Avoid

The Alternate-Day Dosing Trap

  • Never use "20mg every other day" as a tapering strategy 2
  • This creates dramatic fluctuations in serotonin transporter occupancy between doses, triggering withdrawal symptoms 2
  • The variation in receptor occupancy increases as doses decrease, making this approach particularly problematic at lower doses 2

Distinguishing Withdrawal from Relapse

  • Withdrawal symptoms typically occur within days of dose reduction and improve with dose stabilization 3
  • Depression relapse typically emerges more gradually over weeks 5
  • Current guidelines provide inadequate guidance on this distinction, so err on the side of slowing the taper if uncertain 5

The "Therapeutic Minimum" Misconception

  • Standard guidelines recommend tapering to half the minimum therapeutic dose (5-10mg for citalopram) then stopping 3, 5
  • This approach shows minimal benefit over abrupt discontinuation 3
  • Evidence demonstrates that tapering to much lower doses (1-2mg or less) significantly reduces withdrawal symptoms 3

Special Considerations

  • Liquid formulations or compounded preparations may be necessary to achieve very small dose reductions at lower doses 3
  • Some patients may need to pause the taper temporarily and resume when ready—this is acceptable as long as progress is being made 1
  • The taper should be individualized based on withdrawal symptom severity, but the framework above provides the evidence-based structure 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.